ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1260

The Study of Peripheral Blood Lymphocyte Subsets and CD4+T Subsets in Recurrent Polychondritis

Fang Yuan Hu1, Ning Yan 1, Jie Liang 1, Xiao feng li 2 and Cai-hong Wang 3, 1The second hospital of shanxi medical university, Taiyuan, China (People's Republic), 2The Second hospital of Shanxi Medical University, Taiyuan, China (People's Republic), 3The Second Hospital of Shanxi Medical University, Tai Yuan, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: CD4+T subsets, lymphocyte subsets, Recurrent Polychondritis, Treg and immune function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Relapsing polychondritis (RP) is an uncommon systemic connective tissue disorder characterized by recurrent and episodic inflammation of cartilaginous tissues, such as ear, nose, joint, and respiratory tract. Recently, some researches suggest that immune disorders lead to autoimmune diseases. But little research has been done on the status of immune function in RP patients. Therefore, we analyzed the lymphocyte subsets in peripheral blood of RP patients to explore their immune function. Therefore we analyzed absolute counts and percentages of lymphocyte subsets and CD4+T subsets in peripheral blood of RP patients to explore their immune function and laid a foundation for further treatment.

Methods: Absolute counts and percentages of peripheral blood lymphocyte subsets and CD4+T subsets, which were from 17 patients (8 women and 9 men) diagnosed as RP and 17 healthy controls, were assessed  by flow cytometry and compared. All statistical analyses were performed with SPSS v. 22.0. Continuous variables were reported as median. For all study variables, comparison among controls and RP subjects was based on the non-parametric Wilcoxon Mann-Whitney exact test. For all analyses, we used two-sided tests, with p-values < 0.05 denoting statistical significance.

Results: Our study recruited 17 patients who met the inclusion criteria. The average age of patients was 45.23 year. As shown, when compared with healthy controls, RP patients had lower absolute counts of T cells (1573.00/μl vs. 1092.00/μl, p=0.002), CD4+ T cells (913.00/μl vs. 620.09/μl, p=0.003), and NK cells (341.00/μl vs. 203.00/μl, p=0.02). No difference was reported when comparing the percentage and absolute number of B cell, the percentage of CD8+T cells and the ratio of CD4+/CD8+ T cells between RP patients and healthy group. In CD4+ T cells, the proportion and absolute counts of Treg cells were significantly reduced in RP patients in comparison with controls (proportion, 3.80% vs. 5.21%, p< 0.001; absolute counts, 24.28/μl vs. 46.33/μl,p=0.001). The absolute counts of Th2 cells was reduced in RP patients in comparison with controls (7.44/μl vs. 10.22/μl, p=0.031). But there were no significant difference between the percentage and absolute counts of Th17 or Th1 cells in patients with RP and healthy controls. But RP patients had higher ratio of Th17/Treg (0.25 vs. 0.13, p=0.001), Th1/Treg(3.33 vs. 1.95, p=0.018).

Conclusion: Our data suggested that the immune-inflammation in RP patients may be related to the depletion of NK cells and Treg cells. The relative decrease of Treg cells may lead to the relative increase of helper T cells, which leads to uncontrollable inflammatory response.

Table I. Absolute counts and percentage of PB lymphocytes in the study participants -n=17-.

Table II. Absolute counts and percentage of cd4+T cells in the study participants -n=17-.


Disclosure: F. Hu, None; N. Yan, None; J. Liang, None; X. li, None; C. Wang, None.

To cite this abstract in AMA style:

Hu F, Yan N, Liang J, li X, Wang C. The Study of Peripheral Blood Lymphocyte Subsets and CD4+T Subsets in Recurrent Polychondritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-study-of-peripheral-blood-lymphocyte-subsets-and-cd4t-subsets-in-recurrent-polychondritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-study-of-peripheral-blood-lymphocyte-subsets-and-cd4t-subsets-in-recurrent-polychondritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology